These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
x
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from______ to _______
|
|
MOGGLE, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Delaware
|
35-2327649
|
|
|
(State or other jurisdiction of
|
IRS Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
#111 Presidential Boulevard
|
|
Suite 212
|
|
Bala Cynwyd, PA 19004
|
|
(Address of principal executive offices) (Zip Code)
|
|
(215) 463-4099
|
|
(Registrant's telephone number, including area code)
|
|
(Former name, former address and former fiscal year,
|
|
if changed since last report)
|
|
Large Accelerated Filer
o
|
Accelerated Filer
o
|
|
Non-accelerated Filer
o
|
Smaller reporting company
x
|
|
Page
|
||
|
|
||
|
|
||
|
Item 1.
|
Financial Statements
|
1
|
|
Item 2.
|
Management's Discussion and Analysis or Plan of Operation
|
18
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 4.
|
Controls and Procedures
|
|
|
|
||
|
Item 1.
|
Legal Proceedings
|
28
|
|
Item 2.
|
Sales of Unregistered Securities
|
28
|
|
Item 3.
|
Defaults Upon Senior Securities
|
29
|
|
Item 4.
|
Submission of Matters to a Vote of Security Holders
|
29
|
|
Item 5.
|
Other Information
|
29
|
|
Item 6.
|
Exhibits
|
29
|
|
SIGNATURES
|
29
|
|
|
PAGE
|
||||||||
|
BALANCE SHEETS
|
3
|
|||||||
|
STATEMENTS OF OPERATIONS
|
4
|
|||||||
|
STATEMENT OF STOCKHOLDERS' EQUITY
|
5
|
|||||||
|
STATEMENTS OF CASH FLOWS
|
6
|
|||||||
|
NOTES TO FINANCIAL STATEMENTS
|
7 to 17
|
|||||||
|
September 30, 2010
|
December 31, 2009
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$ | 258,081 | $ | 44,710 | ||||
|
Other receivable
|
- | 42,768 | ||||||
|
Prepaid expenses
|
28,235 | - | ||||||
|
Deferred costs
|
7,440 | - | ||||||
|
TOTAL CURRENT ASSETS
|
293,756 | 87,478 | ||||||
|
PROPERTY AND EQUIPMENT
|
||||||||
|
Computer equipment
|
5,582 | 5,582 | ||||||
|
Less: accumulated depreciation
|
2,652 | 1,814 | ||||||
| 2,930 | 3,768 | |||||||
|
OTHER ASSETS
|
||||||||
|
Deposit
|
2,667 | 2,667 | ||||||
|
TOTAL ASSETS
|
$ | 299,353 | $ | 93,913 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
63,233 | $ | 63,115 | |||||
|
Notes payable
|
33,167 | - | ||||||
|
TOTAL CURRENT LIABILITIES
|
96,400 | 63,115 | ||||||
|
STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Preferred stock, $.0001 par value; 2,000,000 shares authorized;
|
||||||||
|
none issued and outstanding at September 30, 2010 and
|
||||||||
|
December 31, 2009
|
- | - | ||||||
|
Common stock, $ .0001 par value; 150,000,000 shares authorized;
|
||||||||
|
51,760,311 and 43,818,703 shares issued and outstanding
|
||||||||
|
at September 30, 2010 and December 31, 2009
|
5,176 | 4,382 | ||||||
|
|
||||||||
|
Additional paid in capital
|
4,619,569 | 3,246,778 | ||||||
|
Deficit accumulated during the development stage
|
(4,421,792 | ) | (3,220,362 | ) | ||||
|
STOCKHOLDERS' EQUITY
|
202,953 | 30,798 | ||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ | 299,353 | $ | 93,913 | ||||
|
Three Months
|
Three Months
|
Nine Months
|
Nine Months
|
|||||||||||||||||
|
Cumulative
|
Ended
|
Ended
|
Ended
|
Ended
|
||||||||||||||||
|
Since
|
September 30,
|
September 30,
|
September 30,
|
September 30,
|
||||||||||||||||
|
Inception
|
2010
|
2009
|
2010
|
2009
|
||||||||||||||||
|
SALES
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
OPERATING EXPENSES
|
||||||||||||||||||||
|
General and administrative
|
293,447 | 93,705 | 33,374 | 118,688 | 74,335 | |||||||||||||||
|
Consulting (a)
|
1,744,221 | 27,590 | 48,009 | 117,099 | 358,919 | |||||||||||||||
|
Payroll (b)
|
740,467 | 152,544 | - | 336,175 | - | |||||||||||||||
|
Professional fees
|
519,048 | 62,465 | 28,754 | 145,620 | 117,239 | |||||||||||||||
|
Research and development
|
131,442 | 18,173 | 62,024 | 18,173 | 92,024 | |||||||||||||||
|
Travel
|
641,416 | 1,589 | 50,754 | 113,092 | 215,497 | |||||||||||||||
|
Total operating expenses
|
4,070,041 | 356,066 | 222,915 | 848,847 | 858,014 | |||||||||||||||
|
OTHER INCOME (EXPENSE)
|
||||||||||||||||||||
|
Interest income
|
834 | - | 1 | 2 | 442 | |||||||||||||||
|
Interest expense
|
(352,585 | ) | (346,350 | ) | - | (352,585 | ) | - | ||||||||||||
| (351,751 | ) | (346,350 | ) | 1 | (352,583 | ) | 442 | |||||||||||||
|
NET LOSS
|
$ | (4,421,792 | ) | $ | (702,416 | ) | $ | (222,914 | ) | $ | (1,201,430 | ) | $ | (857,572 | ) | |||||
|
BASIC AND DILUTED NET LOSS PER
|
||||||||||||||||||||
|
COMMON SHARE
|
$ | (0.01 | ) | $ | (0.01 | ) | $ | (0.02 | ) | $ | (0.02 | ) | ||||||||
|
BASIC AND DILUTED WEIGHTED AVERAGE
|
||||||||||||||||||||
|
COMMON SHARES OUTSTANDING
|
50,634,061 | 38,188,276 | 48,348,099 | 36,999,387 | ||||||||||||||||
|
(a)
|
– includes share-based compensation of $1,458,761 cumulative, $7,004 and $20,954 for the three and nine months ended September 30, 2010, and $14,739 and $237,879 for the three and nine months ended September 30, 2009.
|
|
(b)
|
– includes share-based compensation of $740,467 cumulative, $152,544 and $336,175 for three and nine months ended September 30, 2010 and $0 for the three and nine months ended September 30, 2009.
|
|
Deficit
|
||||||||||||||||||||
|
Common
|
Accumulated
|
|||||||||||||||||||
|
Stock
|
Additional
|
During the
|
||||||||||||||||||
|
Number of
|
Paid-In
|
Development
|
||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Stage
|
Total
|
||||||||||||||||
|
Issuance of initial 19,000,000 shares on February 11, 2008
|
19,000,000 | $ | 1,900 | $ | 17,100 | $ | - | $ | 19,000 | |||||||||||
|
Issuance of shares of common stock
|
13,788,276 | 1,379 | 483,681 | - | 485,060 | |||||||||||||||
|
Exercise of options
|
2,250,000 | 225 | 89,775 | - | 90,000 | |||||||||||||||
|
Exercise of warrants
|
250,000 | 25 | 9,975 | - | 10,000 | |||||||||||||||
|
Fair value of employee stock option grants
|
- | - | 404,292 | - | 404,292 | |||||||||||||||
|
Fair value of non-employee stock option/warrant grants
|
- | - | 108,777 | - | 108,777 | |||||||||||||||
|
Net loss
|
- | - | - | (983,886 | ) | (983,886 | ) | |||||||||||||
|
Balance, December 31, 2008
|
35,288,276 | 3,529 | 1,113,600 | (983,886 | ) | 133,243 | ||||||||||||||
|
Exercise of warrants
|
4,000,000 | 400 | 159,600 | - | 160,000 | |||||||||||||||
|
Exercise of options
|
2,750,000 | 275 | 109,725 | - | 110,000 | |||||||||||||||
|
Issuance of shares of common stock
|
600,000 | 60 | 599,940 | - | 600,000 | |||||||||||||||
|
Stock issuance costs
|
- | - | (65,000 | ) | - | (65,000 | ) | |||||||||||||
|
Fair value of common stock issued for services
|
1,180,427 | 118 | 1,280,309 | - | 1,280,427 | |||||||||||||||
|
Fair value of non-employee stock option/warrant grants
|
- | - | 48,604 | - | 48,604 | |||||||||||||||
|
Net loss
|
- | - | - | (2,236,476 | ) | (2,236,476 | ) | |||||||||||||
|
Balance, December 31, 2009 (Audited)
|
43,818,703 | 4,382 | 3,246,778 | (3,220,362 | ) | 30,798 | ||||||||||||||
|
Exercise of warrants
|
4,392,858 | 439 | 175,275 | - | 175,714 | |||||||||||||||
|
Exercise of options
|
1,000,000 | 100 | 39,900 | - | 40,000 | |||||||||||||||
|
Issuance of shares of common stock
|
2,548,750 | 255 | 800,487 | 800,742 | ||||||||||||||||
|
Fair value of stock option grants
|
- | - | 357,129 | - | 357,129 | |||||||||||||||
|
Net loss
|
- | - | - | (1,201,430 | ) | (1,201,430 | ) | |||||||||||||
|
Balance, September 30, 2010 (Unaudited)
|
51,760,311 | 5,176 | 4,619,569 | (4,421,792 | ) | 202,953 | ||||||||||||||
|
Nine Months
|
Nine Months
|
|||||||||||
|
Cumulative
|
Ended
|
Ended
|
||||||||||
|
Since
|
September 30,
|
September 30,
|
||||||||||
|
Inception
|
2010
|
2009
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
|
Net loss
|
$ | (4,421,792 | ) | $ | (1,201,430 | ) | $ | (857,572 | ) | |||
|
Adjustments to reconcile net loss to net cash
|
||||||||||||
|
used in operating activities
|
||||||||||||
|
Fair value of options issued in exchange for services
|
918,803 | 357,129 | 37,879 | |||||||||
|
Fair value of stock issued in exchange for services
|
1,280,427 | - | 200,000 | |||||||||
|
Amortization of deferred costs
|
70,802 | 70,802 | - | |||||||||
|
Accretion of discount on notes payable
|
280,667 | 280,667 | - | |||||||||
|
Depreciation
|
2,651 | 837 | 837 | |||||||||
|
Provision for bad debt
|
42,768 | 42,768 | - | |||||||||
|
Increase in assets
|
||||||||||||
|
Other receivable
|
(42,768 | ) | - | (42,768 | ) | |||||||
|
Prepaid expenses
|
(28,235 | ) | (28,235 | ) | - | |||||||
|
Deposits
|
(2,667 | ) | - | (2,667 | ) | |||||||
|
Increase in liabilities
|
||||||||||||
|
Accounts payable and accrued expenses
|
63,233 | 119 | 28,832 | |||||||||
|
Net cash used in operating activities
|
(1,836,111 | ) | (477,343 | ) | (635,459 | ) | ||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
|
Puchase of equipment
|
(5,582 | ) | - | - | ||||||||
|
Net cash used in investing activities
|
(5,582 | ) | - | - | ||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from note payable - stockholders
|
247,500 | 247,500 | - | |||||||||
|
Repayment of note payable - stockholders
|
(247,500 | ) | (247,500 | ) | - | |||||||
|
Proceeds from notes payable
|
75,000 | 75,000 | - | |||||||||
|
Proceeds from issuance of common stock
|
1,504,060 | 400,000 | 500,000 | |||||||||
|
Proceeds from exercise of options
|
240,000 | 40,000 | 100,000 | |||||||||
|
Proceeds from exercise of warrants
|
345,714 | 175,714 | 40,000 | |||||||||
|
Stock issuance costs
|
(65,000 | ) | - | (65,000 | ) | |||||||
|
Net cash provided by financing activities
|
2,099,774 | 690,714 | 575,000 | |||||||||
|
NET INCREASE IN CASH AND
|
||||||||||||
|
CASH EQUIVALENTS
|
258,081 | 213,371 | (60,459 | ) | ||||||||
|
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
- | 44,710 | 128,359 | |||||||||
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$ | 258,081 | $ | 258,081 | $ | 67,900 | ||||||
|
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
|
||||||||||||
|
Fair value of common stock issued as discount for notes payable
|
$ | 400,742 | $ | 400,742 | $ | - | ||||||
|
Weighted Average
|
||||||||||||
|
Option
|
Exercise
|
Exercise
|
||||||||||
|
Shares
|
Price
|
Price
|
||||||||||
|
Outstanding, February 11, 2008 (Date of Inception)
|
- | $ | - | $ | - | |||||||
|
Granted
|
6,000,000 | 0.04 | 0.04 | |||||||||
|
Exercised
|
(1,750,000 | ) | 0.04 | 0.04 | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, December 31, 2008
|
4,250,000 | $ | 0.04 | $ | 0.04 | |||||||
|
Granted
|
- | - | - | |||||||||
|
Exercised
|
(2,750,000 | ) | 0.04 | 0.04 | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, December 31, 2009
|
1,500,000 | $ | 0.04 | $ | 0.04 | |||||||
|
Granted
|
2,500,000 |
.75 & 1.00
|
.75 & 1.00
|
|||||||||
|
Exercised
|
(1,000,000 | ) | 0.04 | 0.04 | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, September 30, 2010
|
3,000,000 | $ | .04 to $1.00 | $ | 0.80 | |||||||
|
Exercisable, September 30, 2010
|
500,000 | $ | 0.04 | $ | 0.04 | |||||||
|
Weighted Average Remaining Life,
|
||||||||||||
|
Exercisable, September 30, 2010 (years)
|
2.4 | |||||||||||
|
Weighted Average
|
||||||||||||
|
Option/Warrant
|
Exercise
|
Exercise
|
||||||||||
|
Shares
|
Price
|
Price
|
||||||||||
|
Outstanding, February 11, 2008 (Date of Inception
|
- | $ | - | $ | - | |||||||
|
Granted
|
23,450,002 |
.04 to .75
|
.04 to .75
|
|||||||||
|
Exercised
|
(750,000 | ) | 0.04 | 0.04 | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, December 31, 2008
|
22,700,002 |
$0.04 & $.75
|
$ | 0.04 | ||||||||
|
Granted
|
125,000 | 2.30 | 2.30 | |||||||||
|
Exercised
|
(4,000,000 | ) | 0.04 | 0.04 | ||||||||
|
Expired
|
- | - | - | |||||||||
|
Outstanding, December 31, 2009
|
18,825,002 |
$0.04. $.75 & $2.30
|
$ | 0.09 | ||||||||
|
Granted
|
100,000 | 0.75 | 0.75 | |||||||||
|
Exercised
|
(4,392,858 | ) | 0.04 | 0.04 | ||||||||
|
Retired
|
(400,000 | ) | 0.04 | 0.04 | ||||||||
|
Outstanding, September 30, 2010
|
14,132,144 | $ | 0.04 | $ | 0.11 | |||||||
|
Exercisable, September 30, 2010
|
14,132,144 |
$0.04, $.75 & $2.30
|
$ | 0.11 | ||||||||
|
Weighted Average Remaining Life,
|
||||||||||||
|
Exercisable, September 30, 2010 (years)
|
1.6 | |||||||||||
|
2010
|
8,385 | |||
|
2011
|
11,180 | |||
| $ | 19,565 |
|
Three Months
|
Three Months
|
|||||||
|
Ended
|
Ended
|
|||||||
|
September 30,
|
September 30,
|
|||||||
|
2010
|
2009
|
|||||||
|
Revenues
|
$ | - | $ | - | ||||
|
General and administrative
|
93,705 | 33,374 | ||||||
|
Consulting
|
27,590 | 48,009 | ||||||
|
Payroll
|
152,544 | - | ||||||
|
Professional fees
|
62,465 | 28,754 | ||||||
|
Research and development
|
18,173 | 62,024 | ||||||
|
Travel
|
1,589 | 50,754 | ||||||
|
Interest expense
|
346,350 | - | ||||||
|
Interest income
|
- | (1 | ) | |||||
|
NET LOSS
|
$ | 702,416 | $ | 222,914 | ||||
|
Basic and Diluted Net Loss Per Share
|
$ | (0.01 | ) | $ | (0.01 | ) | ||
|
Basic and Diluted Weighted Average
|
||||||||
|
Outstanding Shares
|
50,634,061 | 38,188,276 | ||||||
|
Compensation Expense of Stock Options
|
$ | 159,548 | $ | 14,739 | ||||
|
Nine Months
|
Nine Months
|
|||||||
|
Ended
|
Ended
|
|||||||
|
September 30,
|
September 30,
|
|||||||
|
2010
|
2009
|
|||||||
|
Revenues
|
$ | - | $ | - | ||||
|
General and administrative
|
118,688 | 74,335 | ||||||
|
Consulting
|
117,099 | 358,919 | ||||||
|
Payroll
|
336,175 | - | ||||||
|
Professional fees
|
145,620 | 117,239 | ||||||
|
Research and development
|
18,173 | 92,024 | ||||||
|
Travel
|
113,092 | 215,497 | ||||||
|
Interest expense
|
352,585 | - | ||||||
|
Interest income
|
(2 | ) | (442 | ) | ||||
|
NET LOSS
|
$ | 1,201,430 | $ | 857,572 | ||||
|
Basic and Diluted Net Loss Per Share
|
$ | (0.02 | ) | $ | (0.02 | ) | ||
|
Basic and Diluted Weighted Average
|
||||||||
|
Outstanding Shares
|
48,348,099 | 36,999,387 | ||||||
|
Compensation Expense of Stock Options
|
$ | 357,129 | $ | 237,879 | ||||
|
Nine Months
|
Nine Months
|
|||||||
|
Ended
|
Ended
|
|||||||
|
September 30,
|
September 30,
|
|||||||
|
2010
|
2009
|
|||||||
|
Net loss
|
$ | (1,201,430 | ) | $ | (857,572 | ) | ||
|
Adjustments to reconcile net loss to net cash
|
||||||||
|
used in operating activities
|
||||||||
|
Compensation expense of stock and stock options
|
357,129 | 237,879 | ||||||
|
Amortization of deferred costs
|
70,802 | - | ||||||
|
Accretion of discount on notes payable
|
280,667 | - | ||||||
|
Depreciation
|
837 | 837 | ||||||
|
Provision for bad debt
|
42,768 | - | ||||||
|
Other receivable
|
- | (42,768 | ) | |||||
|
Prepaid expenses
|
(28,235 | ) | - | |||||
|
Deposit
|
- | (2,667 | ) | |||||
|
Accounts payable and accrued expenses
|
119 | 28,832 | ||||||
|
Net cash used in operating activities
|
(477,343 | ) | (635,459 | ) | ||||
|
Cash flows from Financing Activities
|
||||||||
|
Proceeds from notes payable, net
|
75,000 | - | ||||||
|
Proceeds from issuance of common stock
|
400,000 | 500,000 | ||||||
|
Proceeds from exercise of options/warrants
|
215,714 | 140,000 | ||||||
|
Stock issuance costs
|
- | (65,000 | ) | |||||
|
Net cash provided by financing activities
|
690,714 | 575,000 | ||||||
|
Net increase (decrease) in cash and cash equivalents
|
$ | 213,371 | $ | (60,459 | ) | |||
|
Exercise
|
Options
|
Remaining
|
||||
|
Price
|
Outstanding
|
Life (Years)
|
||||
|
$ 0.04
|
7,850,000 | 2.4 | ||||
|
$ 0.75
|
250,000 | 2.6 | ||||
|
$ 0.75
|
600,000 | 4.9 | ||||
|
$ 2.30
|
125,000 | 3.9 | ||||
|
$ 1.00
|
2,000,000 | 4.4 | ||||
|
Exhibit
|
Identification of Exhibit
|
|
No.
|
|
|
31.1
|
Rule 13a-14(a) Certification of Ernest Cimadamore , President and Principal Executive Officer
|
|
31.2
|
Rule 13a-14(a) Certification of Scott McPherson, Principal Financial Officer
|
|
32.1
|
Certification Pursuant to 18 U.S.C. Section 1350 of Ernest Cimadamore.
|
|
32.2
|
Certification Pursuant to 18 U.S.C. Section 1350 of Scott McPherson.
|
|
By:
|
/s/ Ernest Cimadamore
|
|
|
Ernest Cimadamore, President
|
||
|
and Principal Executive Officer
|
||
|
By:
|
/s/ Scott McPherson
|
|
|
Scott McPherson, ,
|
||
|
Principal Financial Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|